Profiel

Mr. Kyle M.
Lauzon
is a Director-Institutional Sales Group at C.
K.
Cooper & Co. He joined C.
K.
Cooper & Co. in October 2009.
He has 18 years experience in the financial services sector and for the last 10 years has been exclusively focused on institutional research sales in the healthcare and technology sectors.
Most recently, he was a Managing Director of Institutional Equity Sales at Biologic Investment Research, LLC.
Prior to joining Biologic Investment Research, LLC, Mr. Lauzon was the Director of Institutional Equity Sales for Dawson James Securities.
At Dawson James, he was responsible for building out the institutional equities distribution and trading platforms.
Mr. Lauzon also developed and managed regular expert led conference calls, surveys as well as both deal and non-deal corporate road shows.
Mr. Lauzon received multiple awards while at Dawson James in 2006 & 2007 for top institutional production.
In late 2001, Mr. Lauzon joined Sterling Financial Investment Group as an institutional sales representative where by the end of 2002 he had become the desk's top producer and was awarded "MVP" status for his exceptional performance.He holds series 7, 24, and 63 securities licenses.

Eerdere bekende functies van Kyle M. Lauzon

BedrijvenFunctieEinde
Institutionele Verkopen 01-11-2010
Trading-Equity 30-09-2009
Institutionele Verkopen 31-12-2008
Institutionele Verkopen -
Ervaring van Kyle M. Lauzon in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Kyle M. Lauzon in detail bekijken

Connecties

11

Eerstegraads connecties

4

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit4

Finance

Finance

Finance

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Kyle M. Lauzon